(RTTNews) - Q32 Bio Inc. (QTTB) has sold its Phase 2 complement inhibitor ADX-097 to Akebia Therapeutics, Inc. (AKBA), securing upfront and milestone payments that will extend its cash runway into the ...
Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence. Subscribe to TipRanks' Smart Investor Picks and see our data in action through our ...
Extraction and Precipitation of Chitosan from Cell Wall of Zygomycetes Fungi by Dilute Sulfuric Acid
School of Engineering, University of Borås, SE-50190 Borås, Sweden, Chemical and Biological Engineering, Chalmers University of Technology, SE-41296 Göteborg, Sweden, Department of Clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results